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Abstract
Background: Host genetic factors are important determinants in tuberculosis (TB). The SLC11A1 (or
NRAMP1) gene has been studied extensively for genetic association with TB, but with inconsistent findings.
In addition, no study has yet looked into the effect of sex and age on the relationship between SLC11A1
polymorphisms and TB.
Methods: A case-control study was conducted. In total, 278 pulmonary TB patients and 282 sex- and age-
matched controls without TB were recruited. All subjects were ethnic Chinese. On the basis of linkage
disequilibrium pattern, three genetic markers from SLC11A1 and one from the nearby IL8RB locus were
selected and examined for association with TB susceptibility. These markers were genotyped using single
strand conformation polymorphism analysis or fragment analysis of amplified products.
Results: Statistically significant differences in allele (P = 0.0165, OR = 1.51) and genotype (P = 0.0163, OR
= 1.59) frequencies of the linked markers SLC6a/b (classically called D543N and 3'UTR) of the SLC11A1
locus were found between patients and controls. With stratification by sex, positive associations were
identified in the female group for both allele (P = 0.0049, OR = 2.54) and genotype (P = 0.0075, OR = 2.74)
frequencies. With stratification by age, positive associations were demonstrated in the young age group
(age ≤65 years) for both allele (P = 0.0047, OR = 2.52) and genotype (P = 0.0031, OR = 2.92) frequencies.
All positive findings remained significant even after correction for multiple comparisons. No significant
differences were noted in either the male group or the older age group. No significant differences were
found for the other markers (one SLC11A1 marker and one IL8RB marker) either.
Conclusion: This study confirmed the association between SLC11A1 and TB susceptibility and
demonstrated for the first time that the association was restricted to females and the young age group.
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Tuberculosis (TB) remains the worldwide leading cause of
morbidity and mortality due to the infection with Myco-
bacterium tuberculosis (MTB). This successful infectious
agent kills about three million people annually and has
been estimated to infect one-third of the world popula-
tion [1]. The global emergence of TB is due to the pan-
demic of acquired immunodeficiency disease syndrome
and the development of multidrug resistant strains of
MTB [2]. In Hong Kong, TB remains prevalent and is still
a leading cause of death due to infectious diseases in the
past decade [3,4].
Only 10% of individuals infected with MTB develop clin-
ical disease. There are many known factors affecting TB
development, such as age, poverty, sex, alcohol, malnutri-
tion, diabetes and human immunodeficiency virus infec-
tion [5-9]. Host genetic factors are also important
determinants, as are evident from the different concord-
ance rates in monozygotic and dizygotic twins and the
racial difference in susceptibility to MTB infection [10,11].
Of the TB susceptibility genes identified so far, the solute
carrier family 11, member 1 (SLC11A1) gene is the one
most extensively studied. The mouse homolog Slc11a1
was first cloned as the Ity/Lsh/Bcg locus [12]. A point
mutation in this gene resulted in increased susceptibility
in mouse to infections with S. typhimurium, L. donovani
and M. bovis [13-16].
The human SLC11A1 gene, also known as NRAMP1, is
located on chromosome 2q35 and has 15 exons spanning
about 14 kb [17]. The gene encodes a transmembrane
protein expressed exclusively in macrophages/monocytes
and polymorphonuclear leukocytes [18,19]. The protein
is strongly believed to act as a transporter of divalent cati-
ons, in particular iron ions (Fe2+), across the phagosomal
membrane [20-22]. The regulation of Fe2+ level in the
microenvironment of the phagosome is important for the
control of MTB. Since iron is essential for biological sys-
tems, both the human host and the bacterium compete
for iron in favour of effective immunity and establishing
infection, respectively, during infection [23,24]. Hence,
an optimal iron status of the host has to be maintained in
order to limit the availability of this essential nutrient to
the bacteria, but supply it sufficiently to the host defensive
cells for the generation of reactive intermediates of oxygen
and nitrogen [23]. In addition, SLC11A1 has pleiotropic
effects on the activation of macrophages, which play a crit-
ical role in innate immunity against MTB [24].
The relationship between SLC11A1 polymorphisms and
TB has been extensively studied in many different popula-
tions since the first report by Bellamy and co-workers [25].
Although a recent meta-analysis systematically reviewed
and summarized the data published in the last ten years
[26], inconsistencies are common among different stud-
ies. In addition, sex and age of cases and controls were
usually not well matched in most published studies.
Therefore, no study has yet looked into the effect of sex
and age on the relationship between SLC11A1 polymor-
phisms and TB. The present study recruited cases and con-
trols well matched for both factors and reported for the
first time the effect of these factors on the relationship.
Our recent systematic study of the linkage disequilibrium
(LD) pattern of the SLC11A1 locus demands that associa-
tion studies involving SLC11A1 be carried out using
genetic markers from its 5' end like SLC1 and also from its
3' end like SLC6a and SLC6b [27]. True positive associa-
tion results indicate either the direct effect of the SLC11A1
gene itself on the disease of interest or some other nearby
genes because of the LD phenomenon [28]. Our LD study
also indicates that a marker (IL8rb) in the IL8RB locus at
least 220 kb upstream of SLC11A1 is in significant and
strong LD with 5' SLC11A1 markers [27]. The IL8RB gene
encodes one of the receptors for interleukin-8 and is
expressed in neutrophils. This receptor plays a role in the
immune response in infectious diseases and in tuberculo-
sis [29-32]. In view of the LD relationship and the biolog-
ical functions of the IL8RB gene, our LD study also
recommends that the IL8RB locus be tested for association
with TB [27]. Therefore, four markers were tested for asso-
ciation with TB in the present study: SLC1 (alleles (GT)9,
(GT)10 and (GT)11), SLC6a (alleles G and A), SLC6b (alle-
les TGTG and ----) and IL8rb (alleles C and T) (shown in
nomenclature used in our LD study). Other notations that
have been used for these markers include the following:
5'(GT)n or 5'(CA)n for SLC1; D543N or rs17235409 for
SLC6a; 1729+55del4, 3'UTR or rs17235416 for SLC6b;
and CXCR2-786C/T or rs230054 for IL8rb. Since SLC6a
and SLC6b are in perfect LD in Chinese population [27],
they are regarded as a single combined marker SLC6a/b
(alleles G-TGTG and A- ----) in the present study.
Methods
Patients and control subjects
A total of 278 blood samples from unrelated patients with
pulmonary TB (TBP) were collected from three different
local hospitals. All these case subjects were ethnic Chinese
patients with proven pulmonary TB diagnosed by positive
culture results of mainly sputum and very occasionally
bronchial aspirates or washings (with or without positive
acid-fast smear results). Positive culture results were also
confirmed by a nucleic acid-based assay: AccuProbe Myco-
bacterium tuberculosis Complex Culture Identification Test
(Gen-Probe, San Diego, CA, USA) in Haven of Hope Hos-
pital, LCx Mycobacterium tuberculosis Assay (Abbott Labo-
ratories; Abbot Park, Ill, USA) in United Christian
Hospital, or an in-house nested PCR assay [33-35] in
Queen Mary Hospital. Bacteriological and molecular testsPage 2 of 9
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respective collaborating hospitals. Blood samples were
also collected from 282 unrelated Chinese individuals
who were matched with the cases for sex and age, and
were used as control subjects (TBC). Among the controls,
236 samples were from hospital patients without active
pulmonary TB who had negative acid-fast smear results
and did not return for medical consultation for respiratory
symptoms within the 3-year period of subject recruit-
ment. Forty-six samples were from healthy blood donors.
The majority of samples (85% of cases and 84% of con-
trols) were collected from Haven of Hope Hospital. The
study was approved by local institutional review boards.
DNA was extracted from whole blood samples by a mod-
ified salting-out method [36] or by using a Qiagen Blood
Kit (Qiagen, CA, USA).
PCR amplification and genotyping of genetic markers
Three fragments were amplified by polymerase chain reac-
tion for the genotyping of four genetic markers SLC1,
SLC6a, SLC6b and IL8rb, as described in our previous LD
study [27]. Briefly, markers SLC6a and SLC6b were on the
same PCR fragment because of their physical proximity.
SLC6a/b and IL8rb were genotyped by the technique of
single strand conformation polymorphism. SLC1 is a mic-
rosatellite marker and was genotyped by both fragment
analysis on an ABI PRISM 310 Genetic Analyzer (Applied
Biosystems, Foster City, USA) and restriction enzyme
digestion with RsaI (MBI Fermentas, Vilnius, Lithuania).
Statistical analysis
Distribution of genotypes was assessed for Hardy-Wein-
berg equilibrium by χ2 test or exact test if assumptions for
χ2 distribution was violated. Allele and genotype frequen-
cies of cases and controls were compared using χ2 test to
investigate the association between genetic markers and
TB. Odds ratios (OR) with 95% confidence intervals (95%
CI) were also calculated to show the effect size. Correction
for multiple comparisons between cases and controls was
carried out using false discovery rate (FDR) [37]. The FDR
is the expected proportion of true null hypotheses rejected
out of the total number of null hypotheses rejected. The
procedure of controlling the FDR at a level of 0.05 was
performed as described by Benjamini and co-workers
[38].
Results
Demographics
In this case-control study, 278 TB patients (TBP) and 282
sex- and age-matched controls (TBC) without TB were
recruited. Both groups had the same proportion of each
sex (74% male). Both groups also had the same mean age
(65 years old) with very similar standard deviations (18.4
years for TBP and 18.2 years for TBC) and age ranges (14
– 98 years for TBP and 17 – 99 years for TBC).
Relation between SLC11A1 and IL8RB polymorphisms 
and tuberculosis
The distribution of allele and genotype frequencies of the
markers tested is summarized in Table 1. The genotypes of
all polymorphisms in both the TBP and TBC groups were
in Hardy-Weinberg proportions. Markers SLC1 of
SLC11A1 and IL8rb of IL8RB did not show any significant
differences in allele and genotype frequencies between
cases and controls.
On the other hand, the single combined marker SLC6a/b
showed significant differences between TBP and TBC
(Table 1) in the allele frequencies (χ2 = 5.747, P = 0.0165)
and in the genotype frequencies (χ2 = 5.767, P = 0.0163).
With reference to the major allele G-TGTG, the odds ratio
(OR) for the minor allele A- ---- was 1.51 (95% confidence
intervals [CI], 1.08 – 2.12). With reference to the common
homozygous genotype G-TGTG/G-TGTG, genotypes with
at least one copy of the allele A- ---- had a combined OR
of 1.59 (95% CI, 1.09 – 2.32). Since genotypes G-TGTG/
A- ---- and A- ----/A- ---- gave similar ORs (1.57 and 1.83)
and homozygotes A- ----/A- ---- were only found in small
numbers in both groups, the combined OR of 1.59 was
determined. It is important to note that the differences in
allele and genotype frequencies remained significant even
after correction for multiple comparisons (n = 6) by false
discovery rate (FDR) [37] at a level of 0.05 (See additional
file 1).
Stratified analysis for the marker SLC6a/b
The frequency data of the SLC6a/b marker were further
analyzed with stratification of the subjects by sex or age
(Table 2). When the subjects were stratified by sex, signif-
icant differences between TBP and TBC were only
observed in the female group for both allele frequencies
(P = 0.0049, OR = 2.54) and genotype frequencies (P =
0.0075, OR = 2.74). When the subjects were stratified by
age into two groups (≤65 years or > 65 years), significant
differences between TBP and TBC were only found in the
younger age group, also for both allele frequencies (P =
0.0047, OR = 2.52) and genotype frequencies (P = 0.0031,
OR = 2.92). No significant differences were noted in either
the male group or the older age group. The differences
between TBP and TBC in the female group and the
younger age group still remained significant after correc-
tion for multiple testing (n = 8) by FDR at a level of 0.05
(See additional file 1). It was worth noting that the mean
age (in years) remained essentially the same with or with-
out stratification by sex: 65.4 for male TBP and male TBC,
63.7 for female TBP, 63.8 for female TBC, and 65.0 for the
overall TBP and the overall TBC. It was also true that the
proportions of male subjects remained essentially the
same with or without stratification by age: 74% except for
the old TBP (75%). With stratification by age, the meanPage 3 of 9
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TBC, 77.7 for old TBP and 77.6 for old TBC.
When the subjects were stratified by both sex and age, no
significant differences between TBP and TBC were
observed among different sex-age groups after correction
for multiple testing by FDR (Table 3).
Discussion
The present study was a population-based genetic associ-
ation study in which both cases and controls were unre-
lated ethnic Chinese in Hong Kong. That both case and
control subjects were unrelated individuals from the same
ethnic group helps avoid false results due to population
stratification, which of course can also be circumvented
by family-based association studies [39]. Cases were
patients with active pulmonary TB diagnosed by positive
culture results and a molecular assay. Culture is much
more sensitive than direct microscopy although a few
studies reporting the association of SLC11A1 polymor-
phisms and TB relied only on positive direct smears to
identify TB cases [25,40,41]. For the control subjects
recruited in the present study, the majority were hospital
patients who were tested negative for direct smears when
first recruited and were not diagnosed to suffer from pul-
monary TB within the 3-year period of subject recruit-
ment. The use of hospital patients without the disease
under study as control subjects in case-control studies is
well documented [42,43]. In fact, two association studies
of SLC11A1 polymorphisms also recruited hospital
patients as controls [41,44].
As the prevalence of tuberculosis varies with sex and age
[5,6], they are potential confounding factors in case-con-
trol studies of tuberculosis. The present study controlled
these confounders by matching cases and controls for
these two factors: both cases and controls had the same
mean age (65 years old) and the same proportions of both
sexes (74% male). As has been reviewed recently [26],
cases and controls were usually not well matched for gen-
Table 1: Relation between SLC11A1 and IL8R polymorphisms and tuberculosis in Chinese
Alleles/genotypes TB patients Control subjects Odds ratio (95% CI) P value
Comparison of allele frequencies
SLC1a
(GT)9 478 (86%) 493 (87%) 1
Others 78 (14%) 71 (13%) 1.13 (0.80 – 1.60) 0.4780
SLC6a/bb
G-TGTG 462 (83%) 497 (88%) 1
A- ---- 94 (17%) 67 (12%) 1.51 (1.08 – 2.12) 0.0165c
IL8rb
C 370 (67%) 395 (70%) 1
T 186 (33%) 169 (30%) 1.18 (0.91 – 1.51) 0.2096
Comparison of genotype frequencies
SLC1a
(GT)9/(GT)9 204 (73%) 214 (76%) 1
(GT)9/others 70 65
(27%) (24%) 1.14 (1.09 – 2.32) 0.4957
others/others 4 3
SLC6a/bb
G-TGTG/G-TGTG 192 (69%) 220 (78%) 1
G-TGTG/A- ---- 78 57
(31%) (22%) 1.59 (1.09 – 2.32) 0.0163c
A- ----/A- ---- 8 5
IL8rb
C/C 122 (44%) 135 (48%) 1
C/T 126 125
(56%) (52%) 1.17 (0.84 – 1.64) 0.3438
T/T 30 22
a "Others" represent the minor alleles (GT)10 and (GT)11 of the marker SLC1.
b Markers SLC6a and SLC6b are in perfect LD and thus are analyzed as a single marker (SLC6a/b).
c Significant even after correction of multiple testing based on false discovery rate at a level of 0.05. The adjusted cut-off P value is 0.0167 for six 
comparisons. For details, see additional file 1.Page 4 of 9
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[45,46]. For example, the proportion of male patients was
67% while the controls were all male blood donors in one
study [25]. The difference in mean age between cases and
controls could be as large as 19.8 years [47]. In addition,
the mean age could range from 19 years to 58 years for
cases, and from 27 years to 61 years for controls in differ-
ent studies [26].
Both markers SLC1 and IL8rb did not show any statisti-
cally significant difference in allele and genotype frequen-
cies between TBP and TBC in the Chinese population
under study (Table 1). This is consistent with the finding
that IL8rb was found to show strong LD with 5' SLC11A1
markers (like SLC1) but not with 3' SLC11A1 markers
(SLC6a and SLC6b) [27]. The negative finding with IL8rb
of the IL8RB locus is supported by a recent American
study conducted for white Americans and African Ameri-
cans [48]. On the other hand, the negative finding with
SLC1 seems to contradict current evidence. Meta-analysis
of seven studies gave a summary allelic OR of 1.32 (95%
CI, 1.03 – 1.68; P = 0.026) for SLC1 (also called 5'(GT)n
or 5'(CA)n) [26]. Among these seven studies which
included only one study involving Asians (Japanese),
between-study heterogeneity was found for ethnicity,
mean age of cases and study size. In addition, an intrigu-
ing observation is worthy of attention. Among all the
studies reviewed by the meta-analysis, there were six case-
control studies of SLC11A1 that involved Asian popula-
tions (Chinese, Japanese, Korean and Indian) but did not
examine the marker SLC1. One Japanese study did not
examine SLC1 because SLC1 was in perfect LD with INT4
(or SLC3 in the nomenclature of our LD study) [49]. This
study did not find any association between SLC3 and TB,
and this implies that SLC1 was not associated with TB
either in this study. One Chinese study found no associa-
tion between SLC3 and TB susceptibility [45] and this
tends to suggest a negative finding with SLC1 in the light
Table 2: Relation between markers SLC6a/b and tuberculosis in Chinese stratified by sex or agea
Alleles/genotypes TB patients Control subjects Odds ratio (95% CI) P value
Comparison of allele frequencies
Stratification by sex
Male
G-TGTG 352 (85%) 366 (88%) 1
A- ---- 62 (15%) 52 (12%) 1.24 (0.83 – 1.84) 0.2876
Female
G-TGTG 110 (78%) 131 (90%) 1
A- ---- 32 (22%) 15 (10%) 2.54 (1.31 – 4.93) 0.0049b
Stratification by age
Age ≤65
G-TGTG 198 (86%) 218 (94%) 1
A- ---- 32 (14%) 14 (6%) 2.52 (1.31 – 4.85) 0.0047b
Age >65
G-TGTG 264 (81%) 279 (84%) 1
A- ---- 62 (19%) 53 (16%) 1.24 (0.83 – 1.85) 0.3023
Comparison of genotype frequenciesc
Stratification by sex
Male
G-TGTG/G-TGTG 149 (72%) 161 (77%) 1
A- ----/- 58 (28%) 48 (23%) 1.31 (0.84 – 2.03) 0.2370
Female
G-TGTG/G-TGTG 43 (61%) 59 (81%) 1
A- ----/- 28 (39%) 14 (19%) 2.74 (1.29 – 5.82) 0.0075b
Stratification by age
Age ≤65
G-TGTG/G-TGTG 86 (75%) 104 (90%) 1
A- ----/- 29 (25%) 12 (10%) 2.92 (1.41 – 6.07) 0.0031b
Age >65
G-TGTG/G-TGTG 106 (65%) 116 (70%) 1
A- ----/- 57 (35%) 50 (30%) 1.25 (0.79 – 1.989) 0.3479
a Markers SLC6a and SLC6b are in perfect LD and thus are analyzed as a single marker (SLC6a/b).
b Significant even after correction of multiple testing based on false discovery rate at a level of 0.05. The adjusted cut-off P value is 0.0250 for eight 
comparisons. For details, see additional file 1.
c The genotype A- ----/- stands for either A- ----/G-TGTG or A- ----/A- ----.Page 5 of 9
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tion [27]. One Indian study revealed in the discussion sec-
tion that the investigators did not publish the negative
result of association for SLC1 [50]. The reason for examin-
ing other SLC11A1 markers (SLC6a and SLC6b) but not
SLC1 were not stated in the other three studies [51-53]. It
is possible that these authors might have chosen not to
report their negative results. In summary, there is only one
report of positive association between SLC1 and TB sus-
ceptibility in Asian populations. On the contrary, associa-
tion between SLC1 and TB susceptibility is more
consistent in African populations [26]. This observation
raises the possibility of genetic heterogeneity of TB suscep-
tibility with respect to this particular microsatellite marker
although differences in sample size and how TB is diag-
nosed can also produce discrepancies among different
studies. It should also be noted that, in African popula-
tions where both 3' and 5' polymorphisms of the
SLC11A1 locus were found associated with TB susceptibil-
ity, the 3' and 5' polymorphisms in fact contributed sepa-
rate and independent main effects [25,54].
Although SLC3 (or INT4) was not tested in the present
study because of its strong LD with SLC1, it is expected to
give negative finding as SLC1. Meta-analysis of six studies
indeed indicates a negative finding with a summary allelic
OR of 1.14 (95% CI, 0.96 – 1.35; P = 0.13) [26]. In fact,
only one of these six studies gave a positive association
result.
With correction for multiple testing by FDR, our study
showed statistically significant differences in allele and
genotype frequencies of the marker SLC6a/b (i.e., D543N
and 3'UTR) of the SLC11A1 gene between TB patients and
sex- and age-matched control individuals (Table 1). The
present study suggested that the allele A- ---- acted in a
dominant fashion to increase the risk of contracting TB
because the ORs were very similar for both allelic and gen-
otypic comparisons (1.51 and 1.59 respectively), and the
ORs were also similar with either one or two copies of the
allele. However, this can only be regarded as tentative
because the less common homozygotes (A- ----/A- ----)
were found in too small numbers to draw reliable conclu-
Table 3: Relation between markers SLC6a/b and tuberculosis in Chinese stratified by sex and agea
Alleles/genotypes TB patients Control subjects Odds ratio (95% CI) P value
Comparison of allele frequencies
Stratification by sex and age
Male & age ≤65
G-TGTG 151 (89%) 163 (95%) 1
A- ---- 19 (11%) 9 (5%) 2.28 (1.00 – 5.13) 0.0450b
Female & age ≤65
G-TGTG 47 (78%) 55 (92%) 1
A- ---- 13 (22%) 5 (8%) 3.04 (1.01 – 9.16) 0.0408b
Male & age >65
G-TGTG 201 (82%) 203 (83%) 1
A- ---- 43 (18%) 43 (17%) 1.01 (0.63 – 1.61) 0.9668
Female & age >65
G-TGTG 63 (77%) 76 (88%) 1
A- ---- 19 (23%) 10 (12%) 2.29 (0.99 – 5.29) 0.0478b
Comparison of genotype frequenciesc
Stratification by sex and age
Male & age ≤65
G-TGTG/G-TGTG 67 (79%) 79 (92%) 1
A- ----/- 18 (21%) 7 (8%) 3.03 (1.19 – 7.70) 0.0158b
Female & age ≤65
G-TGTG/G-TGTG 19 (63%) 25 (83%) 1
A- ----/- 11 (37%) 5 (17%) 2.90 (0.86 – 9.75) 0.0798
Male & age >65
G-TGTG/G-TGTG 82 (67%) 82 (67%) 1
A- ----/- 40 (33%) 41 (33%) 0.98 (0.57 – 1.66) 0.9276
Female & age >65
G-TGTG/G-TGTG 24 (59%) 34 (67%) 1
A- ----/- 17 (41%) 17 (33%) 2.68 (1.02 – 7.00) 0.0419b
a Markers SLC6a and SLC6b are in perfect LD and thus are analyzed as a single marker (SLC6a/b).
b Not significant after correction of multiple testing based on false discovery rate at a level of 0.05. For details, see additional file 1.
c The genotype A- ----/- stands for either A- ----/G-TGTG or A- ----/A- ----.Page 6 of 9
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the minor alleles of both SLC6a and SLC6b are much less
common in Caucasians than in non-Caucasians [27]. It is
possible that this difference in allele frequency might
partly explain the racial difference in TB susceptibility. The
recently published meta-analysis revealed two important
points [26]. First, meta-analysis of ten studies gave a sum-
mary allelic OR of 1.33 (95% CI, 1.08 – 1.63; P = 0.008)
for SLC6b by random effects. Meta-analysis of nine stud-
ies gave a summary allelic OR of 1.67 (95% CI, 1.35 –
2.05; P < 0.001) for SLC6a by fixed effects. In other words,
both markers are associated with susceptibility to TB.
Interestingly, subgroup analysis indicated consistent pos-
itive association results for both markers for Asian popu-
lations only, but not for European and African
populations. Second, different studies always gave con-
sistent results for these two markers, either both positive
or both negative.
In the present study, the cases and the controls were
matched for both sex and age, and had a very wide age
range (from <20 to about 100 years old). This allowed the
effect of the polymorphisms to be investigated in different
strata. For stratification by age, the cut-off point of 65
years was used in this study as it was the mean age of the
recruited patients and controls. This cut-off point thus
allowed similar sample sizes in both young and old age
groups. In addition, the incidence of tuberculosis tended
to increase between 60 and 70 years of age for the patients
[55-57]. It would thus be interesting to compare the effect
of the polymorphisms in the group with lower incidence
and the group with higher incidence. Indeed, differences
in allele and genotype frequencies were found significant
only in the female group and the younger age group (age
≤65 years), but not in the male group or the older age
group (Table 2). These differences remained significant
even after correction of multiple comparisons by FDR at a
level of 0.05 (See additional file 1). Comparisons were
also tested with stratification by both sex and age, and no
significant result was observed. In this case, the numbers
of subjects in the cells of the contingency tables probably
became too small to give enough power for the stratified
analysis (Table 3). The results indicated that the SLC6a/b
polymorphisms of SLC11A1 contributed to TB develop-
ment in females or those 65 years old or younger. These
findings suggested the importance of sex- and age-match-
ing in both cases and controls since both factors influ-
enced the results in association study. This might explain
some of the inconsistent results in association studies
between SLC11A1 and TB. Note that sex- and age-depend-
ent association between SLC11A1 and TB has not been
reported before. We recommend that this sex- and age-
dependent association be replicated using independent
sample sets from different populations.
Globally, the prevalence of TB is similar in males and
females until adolescence, and higher in males afterwards
[6]. The ratio of female to male TB cases is 1:2 although
the reasons for this difference are unclear. However,
women were reported to be at increased risk of TB during
their reproductive years [6]. In Hong Kong, the prevalence
of TB was consistently higher in men than in women in
the past five decades [58]. Well-developed health organi-
zations monitor and provide health care to both sexes,
and under-notification seems unlikely in Hong Kong.
Thus, biological differences probably account for most of
the difference in TB rate between males and females. Inter-
estingly, only females showed the significant association
between SLC6a/b and TB in the present study. This find-
ing remains to be explained in biological terms. It is also
interesting to note that, due to menstruation, females tend
to have a lower body iron stores [59-61]. This might lead
to a limited supply of iron ions in phagosomes for gener-
ating enough hydroxyl radical for bactericidal activity.
The elderly are a highly susceptible group with a higher
case rate of TB [55,56]. This is due to the presence of other
underlying chronic diseases and the biological changes
associated with ageing. More importantly, the immune
response declines with ageing and hence is impaired in
the microbial clearance mechanisms [62]. As a result, the
elderly are at a higher risk of TB development, which is
more likely due to the ageing effect rather than direct
genetic effects. On the other hand, young adults have
stronger immune system in defence against MTB so that
they are less likely to develop the disease. Therefore, dis-
ease development in young patients is more likely due to
factors other than age. This might explain the positive
association of the SLC11A1 markers SLC6a/b in young
patients rather than in elderly patients with TB. The find-
ing suggests that SLC11A1 as a TB susceptibility gene plays
a significant role in young rather than old patients with
TB.
Conclusion
In conclusion, the present study showed the association of
the polymorphisms SLC6a (D543N) and SLC6b (3'UTR)
of the SLC11A1 locus with TB and supported previous
findings [26]. In addition, IL8RB was tested because of its
strong LD with 5' SLC11A1 markers, and found not asso-
ciated with TB. Our study was the first one that tested the
association of SLC11A1 markers with TB and at the same
time stratified the analysis by sex or/and age. We showed
that the significant association with the 3' polymorphisms
of SLC11A1 was restricted to female patients and to young
patients (age ≤65 years).
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